ArticleAsian journal of pharmaceutical sciences2026
High-dose treatment of cathepsin B-activatable doxorubicin prodrug nanoparticles that induce tumor-specific immunogenic cell death for immunotherapy of melanoma with minimal systemic toxicity.
Yoojeong Oh et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.